Back
Aclaris Therapeutics Stock Predictions
Sponsored
ACRS
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
73
ACRS
Aclaris Therapeutics
Last Price:
2.56
Seasonality Move:
32.55%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeAclaris Therapeutics Stock Forecast
-
Is Aclaris Therapeutics Stock Undervalued?
The current Aclaris Therapeutics [ACRS] share price is $2.55. The Score for ACRS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal. - ACRS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Aclaris Therapeutics Stock Go Up Next Year?
Data Unavailable
Aclaris Therapeutics Stock Rating
Data Unavailable
Aclaris Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aclaristx.com
52-Week Data
52-Week High:
2.68
52-Week Low:
0.59
Prediction Charts
Market Cap:
181.93M
Price in USD:
2.55
Volume:
627.39K
Beta:
0.34
Technical Analysis
SMA50:
1.43
SMA100:
1.33
SMA200:
1.26
52-Wk Change:
-46.37%
Stock Predictions
-
Is Aclaris Therapeutics stock public?
Yes, Aclaris Therapeutics is a publicly traded company. -
What is the Aclaris Therapeutics stock quote today?
The Aclaris Therapeutics stock price is 2.55 USD today. -
How to buy Aclaris Therapeutics stock online?
You can buy Aclaris Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-24 | 1.28 | 1.29 | 1.29 | 1.26 |
Oct-25 | 1.30 | 1.69 | 1.71 | 1.27 |
Oct-28 | 1.55 | 1.61 | 1.65 | 1.52 |
Oct-29 | 1.60 | 1.71 | 1.87 | 1.59 |
Oct-30 | 1.68 | 1.80 | 1.84 | 1.65 |
Oct-31 | 1.82 | 1.81 | 1.94 | 1.80 |
Nov-1 | 1.81 | 2.09 | 2.13 | 1.77 |
Nov-4 | 2.09 | 2.18 | 2.23 | 2.04 |
Nov-5 | 2.18 | 2.22 | 2.31 | 2.15 |
Nov-6 | 2.24 | 2.27 | 2.35 | 2.19 |
Nov-7 | 2.27 | 2.45 | 2.55 | 2.26 |
Nov-8 | 2.48 | 2.63 | 2.67 | 2.48 |
Nov-11 | 2.67 | 2.63 | 2.68 | 2.09 |
Nov-12 | 2.48 | 2.55 | 2.59 | 2.34 |
Aclaris Therapeutics Earnings
Data Unavailable
Aclaris Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and an increase next year of $0.06 per share.
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.